LANCL1 antibody
Principal name
LANCL1 antibody
Alternative names for LANCL1 antibody
LANCL1, GPR69A, LanC-like protein 1, 40 kDa erythrocyte membrane protein, p40
Ncbi ID
9606, ABM84706.1, NP_006046, NP_001130047, NP_001130046, NM_001190984, NM_001190985, NM_021295, NM_053723, NM_001136575, NM_001136574, NP_001177913.1
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of LANCL1 antibody
- Kit Component:
- - KN309126G1, Lancl1 gRNA vector 1 in pCas-Guide vector
- KN309126G2, Lancl1 gRNA vector 2 in pCas-Guide vector
- KN309126D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Zhang W., et al (2009). Genes Dev. 23:1387-1392Blisnick T., et al (2005). Mol. Biochem. Parasitol. 141:39-47
LANCL1 polyclonal antibody (A01), Lot # 050914JC01. Western Blot analysis of LANCL1 expression in human ovary cancer.
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP305279 | LANCL1 (transcript variant 1) |
||||
| Recombinant protein of human LanC lantibiotic synthetase component C-like 1 (bacterial) (LANCL1), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP326718 | LANCL1 (transcript variant 3) |
||||
| Recombinant protein of human LanC lantibiotic synthetase component C-like 1 (bacterial) (LANCL1), transcript variant 3 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP327716 | LANCL1 (transcript variant 2) |
||||
| Recombinant protein of human LanC lantibiotic synthetase component C-like 1 (bacterial) (LANCL1), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR206265L2V | Lenti ORF particles, Lancl1 (GFP-tagged) - Mouse LanC (bacterial lantibiotic synthetase component C)-like 1 (Lancl1), transcript variant 3, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR206265L1V | Lenti ORF particles, Lancl1 (Myc-DDK-tagged) - Mouse LanC (bacterial lantibiotic synthetase component C)-like 1 (Lancl1), transcript variant 3, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR213172L2V | Lenti ORF particles, Lancl1 (GFP-tagged ORF) - Rat LanC lantibiotic synthetase component C-like 1 (bacterial) (Lancl1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR213172L1V | Lenti ORF particles, Lancl1 (Myc-DDK-tagged ORF) - Rat LanC lantibiotic synthetase component C-like 1 (bacterial) (Lancl1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||